The biology of small leucine-rich proteoglycans in bone pathophysiology
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansDecorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cellsTGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and diseaseOncosuppressive functions of decorinDecoding the Matrix: Instructive Roles of Proteoglycan ReceptorsLumican effects in the control of tumour progression and their links with metalloproteinases and integrinsBone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfectaBone composition: relationship to bone fragility and antiosteoporotic drug effectsThe identification of proteoglycans and glycosaminoglycans in archaeological human bones and teethDecorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.Biglycan and decorin differentially regulate signaling in the fetal membranesDecorin differentially modulates the activity of insulin receptor isoform A ligands.Decorin deficiency promotes hepatic carcinogenesisExcessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta.Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury.Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiologyMechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune systemCompensatory fetal membrane mechanisms between biglycan and decorin in inflammation.Tendon functional extracellular matrixDecorin induces rapid secretion of thrombospondin-1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho-associated coiled-coil containing protein kinase 1.Dichotomy of decorin activity on the insulin-like growth factor-I systemMatricellular proteins as regulators of cancer metastasis to bone.Parathyroid hormone/parathyroid hormone-related peptide regulate osteosarcoma cell functions: Focus on the extracellular matrix (Review).Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice.Reprint of: Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells.Decorin-inducible Peg3 Evokes Beclin 1-mediated Autophagy and Thrombospondin 1-mediated AngiostasisMapping the heparin-binding site of the osteoinductive protein NELL1 by site-directed mutagenesis.De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways.Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment.Glycosylation of Dentin Matrix Protein 1 is critical for osteogenesis.Mutations in Biosynthetic Enzymes for the Protein Linker Region of Chondroitin/Dermatan/Heparan Sulfate Cause Skeletal and Skin DysplasiasInnovative technique for the direct determination of proteins in calcified aortic valves.Role of the extracellular matrix in cancer-associated epithelial to mesenchymal transition phenomenon.Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder.Proteoglycans-Biomarkers and Targets in Cancer Therapy.Osteogenesis imperfecta and therapeutics.The role of Tsukushi (TSK), a small leucine-rich repeat proteoglycan, in bone growthBiglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis
P2860
Q21710680-2F7B1004-46FB-4612-A5E4-506914597D9AQ24323987-0FB3B95C-AC08-478A-9B06-EA0DEBF0378AQ26738766-E3C10D8C-D878-4CD6-8CAB-9DE4045AB7FBQ26745697-623F294C-F78B-4AAE-9AF6-60A59D7A5499Q26801397-2C6B3B97-8032-47E5-9952-2245EAAB3697Q26823441-E2A2AD47-4D7A-4A71-826B-0B174B3824C5Q26862184-DE6DA9A8-8D45-42B4-8F00-8A8282CC12C9Q26863596-2FD8EF0F-F274-4140-97D5-C37ECDC8E9F5Q28548675-349C0A77-60C6-4016-8947-9D21C442E31BQ30572396-2611666C-2ADE-4AA6-831B-601E97D205BEQ33690385-044AA2D3-228B-4DB0-9177-07D3C4D1248DQ33690540-04124D7A-3D89-4CA0-9A0D-5832FCE1372CQ33690924-42C10C21-3F4F-4C6D-8620-A298F1F4EEF4Q33721793-921128BE-0B0D-44B5-AA07-D4C618EFE2ACQ33752945-F0CA261B-4013-4C10-8A70-E71DE0D8CD01Q33819300-9D712FFA-7CAD-4A8A-84F0-9098F732D28FQ33831191-7A455C24-71F5-40B6-9F13-F1839F9A07A7Q35629851-1FBA83F9-4F68-4AEB-86C6-C6961A215A94Q35866265-89D3F257-F030-48F7-B9F8-655E34D9D244Q36828327-AAF2E4F0-133B-49A6-8F35-141AAF6F50F3Q36836772-8AFBBF04-0DE5-4CCE-A4CE-C866929D5425Q36923653-52DF83EE-15EF-4EA5-BE11-A2B52292AA39Q37255459-071BB0B5-8BCC-4D34-A748-610980DCFA06Q37384580-0FA7AB03-6312-4CC8-A87D-7FAF7272514AQ37545695-1D74A2E2-AC4C-46BD-AFA8-5D41FD112562Q37735163-7656863E-64DA-4B00-8D7A-8F664EB61E4AQ38815141-F80C7A22-6D01-4C3A-BA76-30B1873098CDQ40099747-E3901174-C976-49DB-8CF0-1A9BB190CA50Q41183987-D02A5DD8-53C8-4170-BEE5-BFB947E4DAF5Q41829260-00B09C95-CC18-44FC-A48A-E273EE99CB94Q42059726-CBFF406F-827A-4B59-8ED3-861338B26499Q47695902-718F9F51-A41C-48DB-AA4A-540D07AE6F0BQ48010288-C0B2303E-EC97-48E6-9E8C-3F78B1DEF8F8Q51026475-C8BBF86B-8914-4C63-A1DF-934DC35A849DQ51732657-9EF008A2-1D9C-4375-B7DC-B4B5B56AE960Q52655586-D55DC542-1B43-4E5A-9FE2-D0DCA89BF89AQ57152198-2AF39847-D08B-400D-888F-B0C63D6AA606Q58573362-323D1804-1F8E-4390-BBDA-F3D482064C04
P2860
The biology of small leucine-rich proteoglycans in bone pathophysiology
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The biology of small leucine-rich proteoglycans in bone pathophysiology
@ast
The biology of small leucine-rich proteoglycans in bone pathophysiology
@en
The biology of small leucine-rich proteoglycans in bone pathophysiology
@nl
type
label
The biology of small leucine-rich proteoglycans in bone pathophysiology
@ast
The biology of small leucine-rich proteoglycans in bone pathophysiology
@en
The biology of small leucine-rich proteoglycans in bone pathophysiology
@nl
prefLabel
The biology of small leucine-rich proteoglycans in bone pathophysiology
@ast
The biology of small leucine-rich proteoglycans in bone pathophysiology
@en
The biology of small leucine-rich proteoglycans in bone pathophysiology
@nl
P2093
P2860
P50
P3181
P356
P1476
The biology of small leucine-rich proteoglycans in bone pathophysiology
@en
P2093
George N Tzanakakis
John Aggelidakis
Marian F Young
P2860
P304
33926-33933
P3181
P356
10.1074/JBC.R112.379602
P407
P577
2012-08-09T00:00:00Z